Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project

PURPOSE: Although treatment for early breast cancer improved prognosis greatly, it can have significant long-term consequences, which must be considered during treatment decision. METHODS: 453 patients with neoadjuvant or adjuvant treatment intention were recruited into the MaTox project within the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurtz, Hans-Jürgen, Tesch, Hans, Göhler, Thomas, Hutzschenreuter, Ulrich, Harde, Johanna, Kruggel, Lisa, Jänicke, Martina, Marschner, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602000/
https://www.ncbi.nlm.nih.gov/pubmed/28677012
http://dx.doi.org/10.1007/s10549-017-4365-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602000/
https://www.ncbi.nlm.nih.gov/pubmed/28677012
http://dx.doi.org/10.1007/s10549-017-4365-7

Ejemplares similares